UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 396

Sortiert nach

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Nature reviews. Gastroenterology & hepatology, 2020-04, Vol.17 (4), p.223

2020

Volltextzugriff (PDF)

The Gut Microbiota at the Service of Immunometabolism

Cell metabolism, 2020-10, Vol.32 (4), p.514-523

2020

Volltextzugriff (PDF)

Gut microbiota-derived metabolites as central regulators in metabolic disorders

Gut, 2021-06, Vol.70 (6), p.1174

2021

Volltextzugriff (PDF)

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Cell host & microbe, 2018-06, Vol.23 (6), p.716-724

2018

Volltextzugriff (PDF)

Tryptophan Metabolism as a Pharmacological Target

Trends in pharmacological sciences (Regular ed.), 2021-01, Vol.42 (1), p.60-73

2021

Volltextzugriff (PDF)

Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine

Genome medicine, 2020-06, Vol.12 (1), p.58-58, Article 58

2020

Volltextzugriff (PDF)

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease

Molecular neurodegeneration, 2022-03, Vol.17 (1), p.19-19, Article 19

2022

Volltextzugriff (PDF)

Clinical,serological and genetic predictors of inflammatory bowel disease course

World journal of gastroenterology : WJG, 2012-08, Vol.18 (29), p.3806-3813

2012

Volltextzugriff (PDF)

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice

Nature communications, 2018-07, Vol.9 (1), p.2802-15, Article 2802

2018

Volltextzugriff (PDF)

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

Gut, 2019-08, Vol.68 (8), p.1504

2019

Volltextzugriff (PDF)

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer

Frontiers in immunology, 2017-11, Vol.8, p.1553-1553

2017

Volltextzugriff (PDF)

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

Gut, 2020-01, Vol.69 (1), p.92

2020

Volltextzugriff (PDF)

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic

Frontiers in microbiology, 2017-06, Vol.8, p.1226-1226

2017

Volltextzugriff (PDF)

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn’s Disease Patients

Journal of Crohn's and colitis, 2016-03, Vol.10 (3), p.296-305

2016

Volltextzugriff (PDF)

Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3

Gut microbes, 2020-11, Vol.12 (1), p.1-16

2020

Volltextzugriff (PDF)

Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study

Microbiome, 2020-02, Vol.8 (1), p.12-12, Article 12

2020

Volltextzugriff (PDF)

Factors affecting outcomes in Crohn's disease over 15 years

Gut, 2012-08, Vol.61 (8), p.1140-1145

2012

Volltextzugriff (PDF)

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model

BMC microbiology, 2015-03, Vol.15 (1), p.67-67, Article 67

2015

Volltextzugriff (PDF)

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii

mBio, 2015-04, Vol.6 (2), p.e00300-15

2015

Volltextzugriff (PDF)

Mucosa-associated microbiota dysbiosis in colitis associated cancer

Gut microbes, 2018-03, Vol.9 (2), p.131-142

2018

Volltextzugriff (PDF)

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Proceedings of the National Academy of Sciences - PNAS, 2008-10, Vol.105 (43), p.16731-16736

2008

Volltextzugriff (PDF)

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction

Frontiers in immunology, 2019, Vol.10, p.143-143

2019

Volltextzugriff (PDF)

Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands

Gut microbes, 2022-12, Vol.14 (1), p.2105637-2105637

2022

Volltextzugriff (PDF)

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease

PLoS biology, 2014-04, Vol.12 (4), p.e1001833-e1001833

2014

Volltextzugriff (PDF)

1 – 25 von 396

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(355)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

The Gut Microbiota at the Service of Immunometabolism

Gut microbiota-derived metabolites as central regulators in metabolic disorders

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Tryptophan Metabolism as a Pharmacological Target

Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease

Clinical,serological and genetic predictors of inflammatory bowel disease course

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice

Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn’s Disease Patients

Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3

Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study

Factors affecting outcomes in Crohn's disease over 15 years

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii

Mucosa-associated microbiota dysbiosis in colitis associated cancer

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction

Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease

Suchergebnisse filtern